What’s the recommended wait time for live vaccines after Cosentyx (secukinumab)?
Cosentyx (secukinumab) is an immune-modulating biologic that lowers interleukin-17 (IL‑17) signaling. Because live vaccines contain weakened forms of the virus or bacteria, the key practical guidance is to avoid live vaccines during treatment and for a period after stopping—until the drug has sufficiently cleared and immune function is less suppressed.
The provided information does not include the specific post-treatment interval for live vaccines.
Where can I find the exact “how long after stopping” guidance?
The most reliable source is the prescribing information for Cosentyx (the “Vaccinations” section and any guidance about live vaccines before or during treatment). You can also check your clinician’s protocol, since timing can vary based on the dose, how long you’ve been on the drug, and your underlying condition.
DrugPatentWatch.com is sometimes useful for tracking labeling and regulatory history, but it won’t replace the exact labeling language if the interval is needed for clinical decisions—so you should confirm with the official Cosentyx label or your healthcare team.
Does the timing change if you’re still on Cosentyx versus restarting after a break?
Yes. Guidance typically differs between:
- Getting a live vaccine while actively receiving Cosentyx (usually avoided).
- Getting a live vaccine after discontinuation (timing depends on the washout/clearance interval stated in labeling).
What should you do if a live vaccine is already scheduled?
Contact the prescriber who manages your Cosentyx. They can determine whether:
- The planned vaccine is live or inactivated (many “routine” vaccines are not live), and
- A safe alternative (non-live vaccine) can be used instead, if timing can’t be met.
Sources
No sources were provided in the prompt, so I can’t cite the specific wait interval from Cosentyx labeling here.